{"transactions":[{"id":1411422,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-10T17:00:15.000Z","date":"2024-09-06","kind":"grant","planned":false,"acquired":true,"shares":14100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (\"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance (\"Grant Date\"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date."}],"balance_after":14100,"derivative":{"exercise_price":3.25,"expiration_date":"2034-09-06","underlying":"Common Stock","underlying_shares":14100},"source":{"system":"sec-edgar","filing":"0001415889-24-023148","document":"form4-09102024_050909.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588924023148/form4-09102024_050909.xml","form_type":"4"}},{"id":1592777,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T18:00:24.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant."}],"balance_after":12500,"derivative":{"exercise_price":4.85,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001415889-24-007098","document":"form4-03062024_060314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588924007098/form4-03062024_060314.xml","form_type":"4"}},{"id":2177357,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-22T17:12:50.000Z","date":"2022-08-18","kind":"purchase","acquired":true,"shares":100000,"price":0.1787,"value":17870.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1772 to $0.1805, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001415889-22-008937","document":"form4-08222022_020840.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588922008937/form4-08222022_020840.xml","form_type":"4"}},{"id":2177356,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-22T17:12:50.000Z","date":"2022-08-18","kind":"purchase","acquired":true,"shares":100000,"price":0.1787,"value":17870.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1772 to $0.1805, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001415889-22-008937","document":"form4-08222022_020840.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588922008937/form4-08222022_020840.xml","form_type":"4"}},{"id":2356976,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T16:13:45.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, which vest in twelve equal monthly installments, beginning on the date of the grant."}],"balance_after":100000,"derivative":{"exercise_price":1.37,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-22-002292","document":"form4-03032022_010333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588922002292/form4-03032022_010333.xml","form_type":"4"}},{"id":2926471,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-04T16:47:20.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total number of shares shall be vested immediately on December 31, 2020 (the \"Vesting Start Date\") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date."}],"balance_after":75000,"derivative":{"exercise_price":1.77,"expiration_date":"2030-12-30","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-21-000005","document":"form4-01042021_010145.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588921000005/form4-01042021_010145.xml","form_type":"4"}},{"id":3169541,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-27T17:10:20.000Z","date":"2020-04-23","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total number of shares shall be vested immediately on April 23, 2020 (the \"Vesting Start Date\") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date."}],"balance_after":75000,"derivative":{"exercise_price":0.398,"expiration_date":"2030-04-23","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-20-001061","document":"form4-04272020_050406.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588920001061/form4-04272020_050406.xml","form_type":"4"}},{"id":3389859,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-22T17:00:40.000Z","date":"2019-10-21","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option shall vest on date of grant October 21, 2019, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter."}],"balance_after":75000,"derivative":{"exercise_price":1.41,"expiration_date":"2029-10-21","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-19-001208","document":"form4-10222019_051020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588919001208/form4-10222019_051020.xml","form_type":"4"}},{"id":3510893,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-28T16:18:58.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option reported herein shall vest on Vesting Start Date May 23, 2019, and 1/36th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter."}],"balance_after":50000,"derivative":{"exercise_price":1,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-19-000595","document":"form4-05282019_010545.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588919000595/form4-05282019_010545.xml","form_type":"4"}},{"id":3829141,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T17:24:47.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests monthly over a period of three years commencing 4/26/2017."}],"balance_after":35000,"derivative":{"exercise_price":1.5,"expiration_date":"2026-11-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-18-001318","document":"form4-08312018_020832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588918001318/form4-08312018_020832.xml","form_type":"4"}},{"id":3829140,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T17:24:47.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"The reporting person agreed to cancellation of an option granted to him on 4/26/2017 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests monthly over a period of three years commencing 4/26/2017."}],"balance_after":0,"derivative":{"exercise_price":1.96,"expiration_date":"2026-11-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-18-001318","document":"form4-08312018_020832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588918001318/form4-08312018_020832.xml","form_type":"4"}},{"id":3829139,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T17:24:47.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests monthly over a period of three years commencing 11/9/2016."}],"balance_after":25000,"derivative":{"exercise_price":1.5,"expiration_date":"2026-11-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-18-001318","document":"form4-08312018_020832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588918001318/form4-08312018_020832.xml","form_type":"4"}},{"id":3829138,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T17:24:47.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The reporting person agreed to cancellation of an option granted to him on 11/9/2016 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests monthly over a period of three years commencing 11/9/2016."}],"balance_after":0,"derivative":{"exercise_price":3.8,"expiration_date":"2026-11-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-18-001318","document":"form4-08312018_020832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588918001318/form4-08312018_020832.xml","form_type":"4"}},{"id":3829137,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T17:24:47.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests monthly over a period of four years commencing 6/19/2016."}],"balance_after":25000,"derivative":{"exercise_price":1.5,"expiration_date":"2026-06-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-18-001318","document":"form4-08312018_020832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588918001318/form4-08312018_020832.xml","form_type":"4"}},{"id":3829136,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T17:24:47.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reporting person agreed to cancellation of an option granted to him on 6/19/2016 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests monthly over a period of four years commencing 6/19/2016."}],"balance_after":0,"derivative":{"exercise_price":3.49,"expiration_date":"2026-06-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-18-001318","document":"form4-08312018_020832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588918001318/form4-08312018_020832.xml","form_type":"4"}},{"id":3829135,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T17:24:47.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":1.5,"exercise_date":"2018-08-29","expiration_date":"2026-03-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-18-001318","document":"form4-08312018_020832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588918001318/form4-08312018_020832.xml","form_type":"4"}},{"id":3829134,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T17:24:47.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person agreed to cancellation of an option granted to him on 3/30/2016 in exchange for a new option having a lower exercise price."}],"balance_after":0,"derivative":{"exercise_price":8,"exercise_date":"2017-03-30","expiration_date":"2026-03-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-18-001318","document":"form4-08312018_020832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588918001318/form4-08312018_020832.xml","form_type":"4"}},{"id":3852236,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-06T17:00:27.000Z","date":"2018-08-05","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option shall vest on Vesting Start Date August 5, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter."}],"balance_after":75000,"derivative":{"exercise_price":1.27,"expiration_date":"2028-08-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-18-001230","document":"form4-08062018_020813.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588918001230/form4-08062018_020813.xml","form_type":"4"}},{"id":4077455,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-05T16:53:25.000Z","date":"2018-02-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option shall vest on date of grant February 2, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter."}],"balance_after":100000,"derivative":{"exercise_price":1.16,"expiration_date":"2028-02-02","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-18-000183","document":"form4-02052018_010200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588918000183/form4-02052018_010200.xml","form_type":"4"}},{"id":4190441,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2017-10-06T17:30:52.000Z","date":"2017-09-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This Amendment to the Form 4 originally filed by the Reporting Person on September 20, 2017 (the \"Original Filing\") is being filed to report (i) the reduction of the exercise price of warrants purchased by Jermax, LLC, an entity controlled by the Reporting Person (\"Jermax\"), and the Reporting Person's spouse from the Issuer on May 31, 2017 in a private placement transaction (the \"Initial Warrants\") and (ii) the issuance of additional warrants to Jermax and the Reporting Person's spouse (the \"Additional Warrants\"). The Issuer's Board of Directors approved the reduction of the exercise price from $4.00 per share to $2.00 per share for the Initial Warrants and all other warrants issued in the same private placement (the \"Spring 2017 Private Placement\"), and the issuance of the Additional Warrants and warrants similar to the Additional Warrants for all other participants in the Spring 2017 Private Placement."}],"balance_after":25000,"derivative":{"exercise_price":2,"exercise_date":"2018-05-19","expiration_date":"2021-04-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-17-001635","document":"form4a-10062017_021041.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588917001635/form4a-10062017_021041.xml","form_type":"4/A","original_submission_date":"2017-09-20"}},{"id":4190440,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2017-10-06T17:30:52.000Z","date":"2017-09-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Jermax, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This Amendment to the Form 4 originally filed by the Reporting Person on September 20, 2017 (the \"Original Filing\") is being filed to report (i) the reduction of the exercise price of warrants purchased by Jermax, LLC, an entity controlled by the Reporting Person (\"Jermax\"), and the Reporting Person's spouse from the Issuer on May 31, 2017 in a private placement transaction (the \"Initial Warrants\") and (ii) the issuance of additional warrants to Jermax and the Reporting Person's spouse (the \"Additional Warrants\"). The Issuer's Board of Directors approved the reduction of the exercise price from $4.00 per share to $2.00 per share for the Initial Warrants and all other warrants issued in the same private placement (the \"Spring 2017 Private Placement\"), and the issuance of the Additional Warrants and warrants similar to the Additional Warrants for all other participants in the Spring 2017 Private Placement."}],"balance_after":25000,"derivative":{"exercise_price":2,"exercise_date":"2018-05-19","expiration_date":"2021-04-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-17-001635","document":"form4a-10062017_021041.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588917001635/form4a-10062017_021041.xml","form_type":"4/A","original_submission_date":"2017-09-20"}},{"id":4190439,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2017-10-06T17:30:52.000Z","date":"2017-09-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This Amendment to the Form 4 originally filed by the Reporting Person on September 20, 2017 (the \"Original Filing\") is being filed to report (i) the reduction of the exercise price of warrants purchased by Jermax, LLC, an entity controlled by the Reporting Person (\"Jermax\"), and the Reporting Person's spouse from the Issuer on May 31, 2017 in a private placement transaction (the \"Initial Warrants\") and (ii) the issuance of additional warrants to Jermax and the Reporting Person's spouse (the \"Additional Warrants\"). The Issuer's Board of Directors approved the reduction of the exercise price from $4.00 per share to $2.00 per share for the Initial Warrants and all other warrants issued in the same private placement (the \"Spring 2017 Private Placement\"), and the issuance of the Additional Warrants and warrants similar to the Additional Warrants for all other participants in the Spring 2017 Private Placement."}],"balance_after":25000,"derivative":{"exercise_price":2,"exercise_date":"2017-12-01","expiration_date":"2021-04-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-17-001635","document":"form4a-10062017_021041.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588917001635/form4a-10062017_021041.xml","form_type":"4/A","original_submission_date":"2017-09-20"}},{"id":4190438,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2017-10-06T17:30:52.000Z","date":"2017-09-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Jermax, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This Amendment to the Form 4 originally filed by the Reporting Person on September 20, 2017 (the \"Original Filing\") is being filed to report (i) the reduction of the exercise price of warrants purchased by Jermax, LLC, an entity controlled by the Reporting Person (\"Jermax\"), and the Reporting Person's spouse from the Issuer on May 31, 2017 in a private placement transaction (the \"Initial Warrants\") and (ii) the issuance of additional warrants to Jermax and the Reporting Person's spouse (the \"Additional Warrants\"). The Issuer's Board of Directors approved the reduction of the exercise price from $4.00 per share to $2.00 per share for the Initial Warrants and all other warrants issued in the same private placement (the \"Spring 2017 Private Placement\"), and the issuance of the Additional Warrants and warrants similar to the Additional Warrants for all other participants in the Spring 2017 Private Placement."}],"balance_after":25000,"derivative":{"exercise_price":2,"exercise_date":"2017-12-01","expiration_date":"2021-04-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-17-001635","document":"form4a-10062017_021041.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588917001635/form4a-10062017_021041.xml","form_type":"4/A","original_submission_date":"2017-09-20"}},{"id":4190437,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2017-10-06T17:30:52.000Z","date":"2017-09-15","kind":"disposition_to_issuer","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This Amendment to the Form 4 originally filed by the Reporting Person on September 20, 2017 (the \"Original Filing\") is being filed to report (i) the reduction of the exercise price of warrants purchased by Jermax, LLC, an entity controlled by the Reporting Person (\"Jermax\"), and the Reporting Person's spouse from the Issuer on May 31, 2017 in a private placement transaction (the \"Initial Warrants\") and (ii) the issuance of additional warrants to Jermax and the Reporting Person's spouse (the \"Additional Warrants\"). The Issuer's Board of Directors approved the reduction of the exercise price from $4.00 per share to $2.00 per share for the Initial Warrants and all other warrants issued in the same private placement (the \"Spring 2017 Private Placement\"), and the issuance of the Additional Warrants and warrants similar to the Additional Warrants for all other participants in the Spring 2017 Private Placement."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2017-12-01","expiration_date":"2021-04-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-17-001635","document":"form4a-10062017_021041.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588917001635/form4a-10062017_021041.xml","form_type":"4/A","original_submission_date":"2017-09-20"}},{"id":4190436,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2017-10-06T17:30:52.000Z","date":"2017-09-15","kind":"disposition_to_issuer","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Jermax, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This Amendment to the Form 4 originally filed by the Reporting Person on September 20, 2017 (the \"Original Filing\") is being filed to report (i) the reduction of the exercise price of warrants purchased by Jermax, LLC, an entity controlled by the Reporting Person (\"Jermax\"), and the Reporting Person's spouse from the Issuer on May 31, 2017 in a private placement transaction (the \"Initial Warrants\") and (ii) the issuance of additional warrants to Jermax and the Reporting Person's spouse (the \"Additional Warrants\"). The Issuer's Board of Directors approved the reduction of the exercise price from $4.00 per share to $2.00 per share for the Initial Warrants and all other warrants issued in the same private placement (the \"Spring 2017 Private Placement\"), and the issuance of the Additional Warrants and warrants similar to the Additional Warrants for all other participants in the Spring 2017 Private Placement."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2017-12-01","expiration_date":"2021-04-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-17-001635","document":"form4a-10062017_021041.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588917001635/form4a-10062017_021041.xml","form_type":"4/A","original_submission_date":"2017-09-20"}},{"id":4190435,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-06T17:30:52.000Z","date":"2017-09-19","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the total number of shares shall be immediately vested upon the Vesting Start Date, 9/19/2017, and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years from the Vesting Start Date."}],"balance_after":50000,"derivative":{"exercise_price":1.56,"expiration_date":"2027-09-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-17-001635","document":"form4a-10062017_021041.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588917001635/form4a-10062017_021041.xml","form_type":"4/A","original_submission_date":"2017-09-20"}},{"id":4205113,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-20T16:35:08.000Z","date":"2017-09-19","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the total number of shares shall be immediately vested upon the Vesting Start Date, 9/19/2017, and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years from the Vesting Start Date."}],"balance_after":50000,"derivative":{"exercise_price":1.56,"expiration_date":"2027-09-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-17-001524","document":"form4-09202017_010957.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588917001524/form4-09202017_010957.xml","form_type":"4"}},{"id":4298714,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2017-06-01T16:56:06.000Z","date":"2017-05-31","kind":"purchase","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Reporting Person's spouse purchased fifty thousand (50,000) Units, at a per-Unit cost of two dollars ($2.00), in the Issuer's private placement, each Unit consisting of one (1) share of unregistsered Common Stock and a warrant to purchase one-half (0.5) share of unregistered Common Stock at an exercise price of $4.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Pegmax, LLC, which is wholly owned and controlled by the Reporting Person's spouse, Margaret P. Gin."}],"balance_after":50000,"derivative":{"exercise_price":4,"exercise_date":"2017-12-01","expiration_date":"2021-04-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-17-000882","document":"form4-06012017_010655.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588917000882/form4-06012017_010655.xml","form_type":"4"}},{"id":4298713,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2017-06-01T16:56:06.000Z","date":"2017-05-31","kind":"purchase","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Jermax, LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reporting Person purchased fifty thousand (50,000) Units, at a per-Unit cost of two dollars ($2.00), in the Issuer's private placement, each Unit consisting of one (1) share of unregistsered Common Stock and a warrant to purchase one-half (0.5) share of unregistered Common Stock at an exercise price of $4.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Jermax, LLC is wholly owned and controlled by the Reporting Person."}],"balance_after":25000,"derivative":{"exercise_price":4,"exercise_date":"2017-12-01","expiration_date":"2021-04-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-17-000882","document":"form4-06012017_010655.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588917000882/form4-06012017_010655.xml","form_type":"4"}},{"id":4298712,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-01T16:56:06.000Z","date":"2017-05-31","kind":"purchase","acquired":true,"shares":50000,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting Person's spouse purchased fifty thousand (50,000) Units, at a per-Unit cost of two dollars ($2.00), in the Issuer's private placement, each Unit consisting of one (1) share of unregistsered Common Stock and a warrant to purchase one-half (0.5) share of unregistered Common Stock at an exercise price of $4.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Pegmax, LLC, which is wholly owned and controlled by the Reporting Person's spouse, Margaret P. Gin."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001415889-17-000882","document":"form4-06012017_010655.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588917000882/form4-06012017_010655.xml","form_type":"4"}},{"id":4298711,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-01T16:56:06.000Z","date":"2017-05-31","kind":"purchase","acquired":true,"shares":50000,"ownership":{"direct":false,"nature":"By Jermax, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased fifty thousand (50,000) Units, at a per-Unit cost of two dollars ($2.00), in the Issuer's private placement, each Unit consisting of one (1) share of unregistsered Common Stock and a warrant to purchase one-half (0.5) share of unregistered Common Stock at an exercise price of $4.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Jermax, LLC is wholly owned and controlled by the Reporting Person."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001415889-17-000882","document":"form4-06012017_010655.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588917000882/form4-06012017_010655.xml","form_type":"4"}},{"id":4342536,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-28T15:30:57.000Z","date":"2017-04-26","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third (1/3rd) of the total shares shall vest one (1) year following the date of grant and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested three (3) years from the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":1.96,"expiration_date":"2027-04-26","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-17-000678","document":"form4-04282017_120446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588917000678/form4-04282017_120446.xml","form_type":"4"}},{"id":4561146,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":87660,"kind":"person","name":"GIN JERRY B","position":1,"cik":"0000901014","reported_name":"GIN JERRY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-10T20:30:16.000Z","date":"2016-11-09","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over a period of three years commencing November 9, 2016."}],"balance_after":25000,"derivative":{"exercise_price":3.8,"expiration_date":"2026-11-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-16-007384","document":"form4-11102016_081106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/901014/000141588916007384/form4-11102016_081106.xml","form_type":"4"}}]}